Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-10 inhibitor PMC

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leishmaniasis 1 D007896 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109460